In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis

por Steenbergen, Judith, Tanaka, S. Ken, Miller, Lynda L., Halasohoris, Stephanie A., Hershfield, Jeremy R.
Publicado 2017

1724. Murine Efficacy Studies of Sulopenem Against Bacillus anthracis

por Puttagunta, Sailaja, Aronin, Steven I, Dunne, Michael, Halasohoris, Stephanie A, Babyak, Ashley, Hourihan, Mary K, Meinig, James M
Publicado 2022

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens

por Halasohoris, Stephanie A., Scarff, Jennifer M., Pysz, Lisa M., Lembirik, Sanae, Lemmon, Margaret M., Biek, Donald, Hannah, Brendan, Zumbrun, Steven D., Panchal, Rekha G.
Publicado 2021

Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest

por Barnes, Kay B., Zumbrun, Steven D., Halasohoris, Stephanie A., Desai, Purvi D., Miller, Lynda L., Richards, Mark I., Russell, Paul, Bentley, Christine, Harding, Sarah V.
Publicado 2019

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

por Otvos Jr., Laszlo, Ostorhazi, Eszter, Szabo, Dora, Zumbrun, Steven D., Miller, Lynda L., Halasohoris, Stephanie A., Desai, Puvi D., Int Veldt, Sharon M., Kraus, Carl N.
Publicado 2018

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague M...

por Amemiya, Kei, Dankmeyer, Jennifer L., Keasey, Sarah L., Trevino, Sylvia R., Wormald, Michael M., Halasohoris, Stephanie A., Ribot, Wilson J., Fetterer, David P., Cote, Christopher K., Worsham, Patricia L., Adamovicz, Jeffrey J., Ulrich, Robert G.
Publicado 2020